GL1X · GenesisL1 explorer

Research workbench

Crystal structure of bbki, a kunitz-type kallikrein inhibitor

Analyse Crystal structure of bbki, a kunitz-type kallikrein inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2GO2
Type
protein
Length
163 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Kunitz-type serine protease inhibitor bbki
UniProt
P83052

Structure

x-ray diffraction · 1 distinct chain · 0% helix, 47% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AKunitz-type serine protease inhibitor bbkiprotein1630% helix, 47% strandP83052

Ligands and binding sites

  • EDO · 1,2-ethanediol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 2GO2 · Crystal structure of BbKI, a Kunitz-type kallikrein inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P83052 · AlphaFold monomer V2.0 prediction for kunitz-type serine protease inhibitor bbki (P83052) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.